[1]
Murtezani, A. 2017. Comparison of Clinical Effectiveness of Folfirinox versus Gemcitabine on Quality of Life in Patients with Pancreatic Cancer Stage IV. Asian Journal of Pharmaceutics (AJP). 11, 03 (Oct. 2017). DOI:https://doi.org/10.22377/ajp.v11i03.1468.